Corporate DisclosureIBP
IBP Corporate Disclosure — 12 May 2019
Announcement summary
- What happened
- IBP published a corporate disclosure on 12 May 2019. Read the full announcement for details.
- Company
- Indo-Bangla Pharmaceuticals Limited
- Announcement published
Original announcement
The Company has informed that the Board of Directors has approved Toll Manufacturing Agreement with NIPRO JMI Pharma Ltd., Dhaka, Bangladesh for contract Manufacturing of Antibiotic, Cephalosporin and Penicillin products on behalf of Indo-Bangla Pharmaceuticals Ltd. to meet increased demand of existing products and to introduce new products.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aced55a6b000040059d4c
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from IBP
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.